AERA has developed software that enables health and wellbeing practitioners to provide personalized and preventive care for their clients. To that end, the company’s hybrid model brings data-driven “P4” medicine to consumers via existing healthcare infrastructure. Said P4 medicine uses data to foresee patient issues (predictive), acts to prevent rather than cure diseases (preventive), makes …

Founded as a spin-off of the University Hospital of Bern, Inselspital – machineMD is developing a novel diagnostic device that enables complete standardized and automated neuro-ophthalmic examinations. Uniquely combining virtual reality and artificial intelligence, the device will measure biomarkers such as eye and pupil movements that can be used in the early diagnosis of brain …

Healthcare Automation and Digitalization Congress is an annual B2B networking event for more than 250 professionals from the whole value chain of the healthcare industry, including Roche, Bayer, Johnson & Johnson, Oxford University Hospital, University Hospital Zurich, and many others. During 2 days of intensive networking AUTOMA+ participants present their case studies, exchange experiences, and …

Intelligent Health AI is a CPD-accredited summit that brings together the global AI and health communities to advance discussions on how to apply AI and drive technological collaboration in healthcare, by connecting clinicians, patients and decision-makers in healthcare settings with technologists. As they say, be ready to think like a physician and code like a …

An initiative of Impact Hub Zürich and launched by digitalswitzerland, Kickstart is one of Europe’s largest zero equity, multi-corporate ecosystem innovation platforms that run a scale-up program for later-stage startups with a goal to accelerate deep tech innovation. It is building an ecosystem that brings together high-growth startups, corporates, cities, foundations, and universities. To that …

VI Partners is a Swiss venture capital firm providing university spin-offs as well as other promising start-up companies with capital, coaching, and networks. VI Partners is also the advisor to multiple funds. The first fund was established by McKinsey & Company and the Swiss Federal Institute of Technology in Zürich (ETHZ) in 2001.

Terapet has developed an add-on device to improve existing proton therapy, which is an advanced form of radiotherapy for cancer treatment that can target tumors with extreme precision. It is a non-invasive medical device placed close to the patient during the treatment to enable doctors to monitor the delivered proton dose inside the patients during …

EarlySight aims to reduce vision loss by enabling efficient detection and better monitoring of eye diseases. The company develops a high-performance eye imaging instrument in the form of a unique ophthalmic camera, empowering doctors to see the first disease impacts. Its technology allows visualizing the morphology of many cells in the retina that are playing …

VirtaMed is a medical training company that uses high fidelity VR simulators for minimally invasive diagnostic and therapeutic interventions in orthopedics, urology, ob/gyn and general surgery. Combining VR graphics with original instruments and anatomic models for realistic tactile feedback, VirtaMed simulators provide structured courses and performance-based proficiency assessments. The company partners with medical societies and …

Formerly known as HIT Foundation, the dHealth Foundation aims to align the incentives for all stakeholders in the healthcare system thereby making their processes more efficient, transparent, and valuable. It allows for easy adoption of blockchain technology for individual users and organizations. dHealth Network is not controlled by any single player, can be accessed directly …

MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain’s ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence – its healthcare division is addressing some of the most challenging problems in neurology, …

Guardtime is one of the largest providers of enterprise blockchain-based security systems. Its technology uses a Keyless Signature Infrastructure (KSI) to provide large-scale data authentication. The company struck a partnership with the Estonian e-Health Authority in March 2016 to secure over 1 million patient records. The company’s offering also includes VaccineGuard, which is a distributed …

A venture capital firm that manages funds which invest in private companies developing and marketing drugs and medical devices or providing healthcare services.

ABB Technology Ventures (ATV) scouts the globe for power and automation technology partners aligned with ABB’s goal to write the future of industrial digitalization.

LGT Capital Partners is a leading alternative investment specialist with more than 600 institutional clients in 43 countries. Its international team is responsible for managing a wide range of investment programs focusing on private markets, liquid alternatives, and multi-asset class solutions. In addition to its headquarters in Switzerland, the firm has offices in New York, …

Formerly called Aeris Capital AG, Calibrium is a private equity fund and financial advisor that is active in all asset classes globally.

Novartis Venture Fund (NVF) is a stage-agnostic venture arm of Novartis, engaging in investments from seed- to later-stage life sciences companies across Biotechnology/Biopharma, Medical Devices, and Diagnostics. Its primary focus is on the development of novel therapeutics and platforms, with a preference to either lead or co-lead an investment and play an active role on …

A corporate venture fund of Roche, it makes investments in life science companies aiming to create value by fostering innovation, guiding successful businesses, and generating a financial return for Roche. Roche Venture Fund is looking for private companies with innovative medicines, diagnostics, and technologies. In select cases, it will invest in companies alongside research and …